Sources

8 Total Sources

Pelacarsen, Ziltivekimab Show 0 Benefit in Heart Trials After High Hopes

Left50%
Center50%
The New York Times1h ago
Heart Drugs Pelacarsen, Ziltivekimab Fail Clinical Trials
Bloomberg1h ago
Novartis Abandons Heart Drug After Surprising Failure in Key Study - Bloomberg
Reuters1h ago
Trial failures of Novartis, Novo Nordisk heart drugs leave experts guessing | Reuters
news.massgeneralbrigham.org1h ago
Heart researchers unpack neutral findings from ZEUS, an anti-inflammatory clinical trial | Mass General Brigham
WLIW1h ago
A promising new medicine against heart disease fails unexpectedly | News | WLIW-FM
AD HOC NEWS1h ago
Novo Nordisk's Failed Heart Drug Trial Leaves Little Room for Error in Wednesday's Earnings Report
MD Magazine1h ago
Lp(a) HORIZON Shows Pelacarsen Lowers Lp(a) 78% But Not Cardiovascular Events | HCPLive
Yahoo! Voices1h ago
Novartis heart drug failure leaves doctors seeking evidence for genetic cholesterol target